PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
15-Jan-2024 Verisma Rated Top Release of Information and Audit Management Solution, 2023 Black Book Revenue Integrity Client Survey AccessWire
15-Jan-2024 Drägerwerk AG & Co. KGaA: Preliminary figures 2023: Net sales and earnings significantly above prior year – Dividend increase – Forecast 2024 Drägerwerk AG & Co. KGaA
15-Jan-2024 Theralase(R) Provides Update on Phase II Bladder Cancer Clinical Study AccessWire
15-Jan-2024 Hyris Fulfils Its Integration Into Ulisse Biomed to Give Birth to a New International Group Ready to Make Its Mark in the Global Biotech Market Newswire
15-Jan-2024 Hyris Fulfils Its Integration Into Ulisse Biomed to Give Birth to a New International Group Ready to Make Its Mark in the Global Biotech Market AccessWire
15-Jan-2024 Strategic Insights into the Mass Spectrometry Market: Key Players and Market Dynamics Markets and Markets
15-Jan-2024 DOUGLAS with strong first quarter 2023/24 - growth strategy on track Douglas GmbH
15-Jan-2024 Spexis announces sale of preclinical antibiotics program to Basilea Spexis AG
13-Jan-2024 SunTech Launches Vet40: A Next-Gen Surgical Vital Signs Monitor for Companion Animals AccessWire
13-Jan-2024 Latest Analysis Reveals 65% of US Biotechs Struggle to Identify Suitable CRO Partner Avance Clinical
12-Jan-2024 Notice of Deficiency with Nasdaq Continued Listing Requirements AccessWire
12-Jan-2024 Advanced Addiction Center Announces Grand Opening of New Outpatient Center on January 13, 2024 Newswire
12-Jan-2024 Advanced Addiction Center Announces Grand Opening of New Outpatient Center on January 13, 2024 AccessWire
12-Jan-2024 Navix Health Selects SOBRsafe as Exclusive Alcohol Data Partner for Next-Generation Digital Healthcare Platform AccessWire
12-Jan-2024 Evaluate announces acquisition of J+D Forecasting Evaluate
12-Jan-2024 Avery Dennison at Pharmapack 2024: showcasing the latest technologies that boost patient safety Avery Dennison
12-Jan-2024 HUTCHMED Announces NDA Acceptance in China for Sovleplenib for the Treatment of Primary Immune Thrombocytopenia with Priority Review Status HUTCHMED
12-Jan-2024 Boehringer Ingelheim signs a two-year agreement with Qlucore Boehringer Ingelheim
12-Jan-2024 Leading Pharma Adopts Veeva Vault Validation Management for Digital Validation Execution and Improved Efficiency SK Life Science
12-Jan-2024 Conference Call on Report on Operations 2023 AccessWire